Navigation Links
SPO Announces Completion of Rebranding Program
Date:11/4/2010

SPO Announces Completion of Rebranding Program -- NEW YORK, November 4, 2010 /PRNewswire-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Web Site, Biotechnology, Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, General Sports, New Products & Services Click to view news release full screen  

SPO Announces Completion of Rebranding Program

 

NEW YORK, November 4, 2010 /PRNewswire-FirstCall/ --

- Company Positioned for Growth via Consumer-Related Wellness Applications

SPO Medical Inc. (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, today announced it has completed its rebranding program so it can operate primarily on consumer-related wellness applications. The company will now focus on several vertical applications based on its proprietary technology platform. Moving forward, SPO will operate divisionally through the SPO Wellness(TM), SPO Medical, SPO Baby and SPO Security product lines. Additionally, a new corporate web site and company logo has been launched that can be viewed at http://www.spoglobal.com.

Michael Braunold, President and Chief Executive Officer of SPO commented, "This is an important milestone for the company and its shareholders. With our ability to now focus on vertical market opportunities, we can maximize the value of our technology through commercial partnerships to promote our consumer product lines. Our experience in developing and launching several successful medical product offerings enables us to now effectively focus on mass-market, consumer opportunities going forward. Our primary market is in the wellness space and we are in the latter stages of preparing for launch of our new SPO Wellness(TM) product line. We achieved this through our partnership with Brewer Sports International (BSI), the world's fastest growing multi-faceted advisory firms with a focus on the business of sports and wellness."

As part of this launch program, SPO recently announced that it has signed with several high-profile, professional athletes who have agreed to endorse the SPO Wellness(TM) line of products. This includes the world's first performance monitoring wristband, known as the Wellness 10k(TM). The Wellness 10k(TM) is designed for both children and adults and features a display function to continuously measure the number of daily activities against preset recommended goals. Furthermore, an innovative heart-rate monitor sports watch has also been developed to measure continuous heart-rate without the need to wear a conventional chest strap, unlike many other heart-rate monitor watches that are on the market.

Both SPO Wellness(TM) products are currently at an advanced stage of development and SPO expects the Wellness 10k(TM) wristband to be launched later this month for test marketing followed by a full commercial roll-out in 2011. Braunold continued, "We believe our partnership with BSI along with the secured endorsements and our rebranding efforts will help us bring a cost-effective solution to the vast consumer wellness market, which in turn contributes to potentially increasing value for the SPO shareholders."

About SPO

SPO (SPOM) is a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices to capture life-enhancing information within four key markets: medical care; sports and wellness; homecare monitoring and security. Its patented technology uses information gathered from the reflectance of light on the human body, in a noninvasive manner, to monitor key vital signs. The company manufactures its products in addition to licensing its technologies to appropriate client corporations for commercialization and distribution. For more information, visit http://www.spoglobal.com.

Forward Looking Statements

This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry, and that reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to, market acceptance of our products and new product applications, timing of new product launches, success of the Company's rebranding program, product performance, size of prospective markets, revenues assessments, success of our restructured operations and plans, our ability to generate fees or raise capital to support our business operations and plan, the sufficiency and availability of working capital, changes in economic conditions generally and in more specifically, the introduction of competing products, changes in our operating strategy or development plans patent protection for our products and technologies, changes in economic conditions generally and in more specifically, in the markets we operate, changes in technology, legislative or regulatory changes that affect us and the risks and uncertainties discussed under the heading "Risk Factors" in Item 1 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2009. We undertake no obligation to revise or update any forward-looking statement for any reason.

Websites: http://www.spoglobal.com; http://www.spowellness.com; http://www.spomedical.com; http://www.spobaby.com; http://www.sposecurity.com

Twitter: http://www.twitter.com/spowellness Facebook: http://www.facebook.com/spowellness Contacts regarding this release: Michael Braunold, Chief Executive Officer investors@spoglobal.com +1-866-991-7766
'/>"/>

SOURCE SPO Medical Inc
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Research and Markets has announced the addition of the "R&D ... ... R&D Drug Pipeline Database: 1-Year Subscription Subscription ... online access to information about more than 21,000 project entries (files) ... in research & development. Pre-established and free search ...
(Date:12/2/2016)... December 2, 2016 Persistence Market ... market in its upcoming report titled, "Global Market Study on Cardiac ... CAGR of -1.4% between 2016 and 2024". The global cardiac ... 2015 and this is likely to decline to US$ ... global cardiac pacemaker market is anticipated to exhibit a ...
(Date:12/2/2016)... DUBLIN , Dec 2, 2016 Research ... Market Size, Share, Development, Growth and Demand Forecast to 2022" report ... , , ... revenue of $6 billion in 2015, and it is expected to grow ... ultrasound segment is expected to witness faster growth during the forecast period, ...
Breaking Medicine Technology:
(Date:12/4/2016)... , ... December 03, 2016 ... ... Newall wins "Best Surgical Body Shaping" at the 2016 Anti-Aging & ... Paris, France. , The Aesthetic & Anti-Aging Medicine European Congress (AMEC) ...
(Date:12/4/2016)... ... , ... Responsible dental care hinges on regular brushing of the teeth. However, ... important necessity inspired an inventor from Las Vegas, Nev., to design the BRUSH PROPER. ... or avoid bad techniques of brushing the teeth in order to prevent cavities," he ...
(Date:12/2/2016)... ... ... twenty-four years, Doctors on Liens has published a directory of the top doctors ... When the company started in 1997, the directory was a single page focusing on ... ten-page directory features a vast array of medical specialists stretching from Sacramento to ...
(Date:12/2/2016)... ... , ... The annual time frame to change Medicare health and prescription drug ... 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current plan to ... make changes during this period order for their new policy to go into effect ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... from high school and while 84 percent of parents report speaking with their child ... control, pornography and sexually transmitted diseases. , Mediaplanet is proud to announce the launch ...
Breaking Medicine News(10 mins):